Purchasers Seek Class Status In Ditropan Case

Indirect purchasers of Ditropan XL are seeking class status in their antitrust action against Alza Corp. for allegedly blocking generic copycats of the bladder treatment from entering the U.S. market, less...

Already a subscriber? Click here to view full article